Skip to content

Search

National guideline to tackle record rates of skin infection

Researchers have developed the first National Healthy Skin Guideline to address record rates of skin infections in Australia’s Indigenous communities.

Perth mums play instrumental part in world-first vaccine

New mothers in Perth are teaming up with researchers at The Kids Research Institute Australia in a global bid to develop the first vaccine to prevent Respiratory Syncytial Virus (RSV) disease.

New RHD research collaboration with Danila Dilba Health Service

The Kids Research Institute Australia and Menzies School of Health Research have joined forces with Danila Dilba Health Service to look at improving treatment for RHD.

Inaugural Winner of the Deborah Lehmann Research Award

Congratulations goes to Celestine Aho, the inaugural winner of the $30,000 Deborah Lehmann Research Award.

$2 million grant to develop diagnostic tool for rheumatic fever

The Kids Research Institute Australia & Menzies School of Health Research will lead an international project to develop a diagnostic tool for acute rheumatic fever.

The Kids researcher awarded Research Translation Projects grant

A new research project aims to demonstrate how influenza vaccination in children could be a highly cost-effective health care intervention in Australia.

Skin infections flying under the radar

The Kids Research Institute Australia researchers have confirmed that skin infections in many Aboriginal children across northern Western Australia are going unrecognised.

Expanded FluMist® program gives more young Western Australians access to needle-free flu protection

More young Western Australians will have access to needle-free protection against influenza this winter, with the WA Government expanding its nation-leading FluMist® program to include teenagers aged 12 to 17 years.

Taking the fight to RSV from all angles

Respiratory Syncytial Virus (RSV) is a year-round threat to the health of babies and young children, and one of the leading causes of infant hospitalisation in Australia. It is highly contagious and can cause anything from mild cold-like symptoms to severe lung infections such as bronchiolitis and pneumonia. For n

Australia’s first RSV immunisation program cuts newborn hospitalisations by almost half

Australia’s new respiratory syncytial virus (RSV) immunisation program cut hospital admissions for Australia’s youngest babies by almost half in its first year, a new major national study has shown.